✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Krebs Biochemicals & Industries Ltd.

KREBSBIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹151 Cr.
P/E
0.00

Krebs Biochemicals & Industries Ltd.

  • Krebs Biochem.&Inds
  • Kimia Biosciences
  • Achyut Healthcare

FAQs on Krebs Biochemicals & Industries Ltd. Shareprice

Krebs Biochem.&Inds has given lower returns compared to its competitors.
Krebs Biochem.&Inds has grown at ~-16.78% over the last 3yrs while peers have grown at a median rate of 5.39%

There is insufficient historical data to gauge this.
Latest PE of Krebs Biochem.&Inds is 0

View FAQ's On Business

Growth Table

  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Balance Sheet

  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Cash Flow

  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Quarterly Results

  • Krebs Biochemicals & Industries Ltd.
  • Kimia Biosciences
  • Achyut Healthcare

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Krebs Biochemicals & Industries Ltd. Financials

Krebs Biochem.&Inds balance sheet is weak and might have solvency issues

Yes, The net debt of Krebs Biochem.&Inds is increasing.
Latest net debt of Krebs Biochem.&Inds is ₹212 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹193 Crs.

No, profit is decreasing.
The profit of Krebs Biochem.&Inds is -₹27.09 Crs for TTM, -₹27.02 Crs for Mar 2025 and -₹19.75 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Krebs Biochem.&Inds latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech